Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,348 | 180 | 60.6% |
| Consulting Fee | $2,800 | 1 | 39.0% |
| Travel and Lodging | $14.84 | 1 | 0.2% |
| Education | $9.60 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $2,852 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $705.52 | 29 | $0 (2022) |
| Abbott Laboratories | $561.81 | 6 | $0 (2022) |
| Medtronic, Inc. | $353.05 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $344.95 | 25 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $334.08 | 18 | $0 (2022) |
| Gilead Sciences, Inc. | $193.15 | 18 | $0 (2019) |
| Shockwave Medical, Inc | $187.50 | 1 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $176.69 | 10 | $0 (2019) |
| PFIZER INC. | $154.37 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $321.07 | 3 | Medtronic, Inc. ($305.84) |
| 2023 | $49.48 | 3 | Inari Medical, Inc. ($19.34) |
| 2022 | $777.64 | 35 | Abbott Laboratories ($185.93) |
| 2021 | $592.12 | 13 | Shockwave Medical, Inc ($187.50) |
| 2020 | $340.12 | 9 | AstraZeneca Pharmaceuticals LP ($155.42) |
| 2019 | $515.14 | 31 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($97.13) |
| 2018 | $1,014 | 50 | Janssen Pharmaceuticals, Inc ($465.25) |
| 2017 | $3,563 | 39 | Philips Electronics North America Corporation ($2,827) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/18/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $136.45 | General |
| Category: Transcatheter Valve Systems | ||||||
| 03/07/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $169.39 | General |
| Category: Transcatheter Valve Systems | ||||||
| 04/04/2023 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: PAD | ||||||
| 01/26/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/05/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: VTE | ||||||
| 12/30/2022 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiology | ||||||
| 12/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology | ||||||
| 11/21/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2022 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: PAD | ||||||
| 11/15/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardiology | ||||||
| 11/02/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/13/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: VTE | ||||||
| 09/27/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Cardiovascular | ||||||
| 09/02/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/26/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: VTE | ||||||
| 07/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/02/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,006 | 1,256 | $312,206 | $57,658 |
| 2022 | 48 | 9,146 | 12,449 | $2.2M | $908,243 |
| 2021 | 52 | 10,024 | 14,414 | $2.5M | $978,109 |
| 2020 | 53 | 10,026 | 14,691 | $2.8M | $1.0M |
All Medicare Procedures & Services
188 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 30 | 60 | $17,250 | $13,524 | 78.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 30 | 30 | $25,770 | $8,291 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 269 | 270 | $35,900 | $6,711 | 18.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 110 | 110 | $36,561 | $6,378 | 17.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 27 | 108 | $9,936 | $5,180 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 82 | $15,662 | $3,591 | 22.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $38,598 | $2,951 | 7.6% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Office | 2023 | 31 | 159 | $43,725 | $2,864 | 6.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 61 | 61 | $33,810 | $2,266 | 6.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 32 | 32 | $5,792 | $1,491 | 25.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 24 | 24 | $18,136 | $1,092 | 6.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 26 | $3,812 | $1,078 | 28.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 94 | 95 | $5,090 | $468.98 | 9.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 21 | 21 | $3,950 | $370.40 | 9.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 26 | 26 | $5,204 | $354.80 | 6.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 12 | 12 | $3,300 | $296.97 | 9.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 26 | 26 | $3,830 | $243.25 | 6.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 23 | 23 | $3,210 | $209.80 | 6.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 23 | 23 | $1,305 | $120.26 | 9.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 21 | 22 | $550.00 | $112.42 | 20.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 29 | 29 | $815.00 | $66.22 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,166 | 1,669 | $318,779 | $150,914 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,419 | 2,289 | $297,570 | $140,450 | 47.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 320 | 641 | $177,513 | $138,522 | 78.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 319 | 320 | $274,880 | $108,819 | 39.6% |
About Dr. Michael Yandel, MD
Dr. Michael Yandel, MD is a Cardiovascular Disease healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578664140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Yandel, MD has received a total of $7,173 in payments from pharmaceutical and medical device companies, with $321.07 received in 2024. These payments were reported across 183 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,348).
As a Medicare-enrolled provider, Yandel has provided services to 30,202 Medicare beneficiaries, totaling 42,810 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 188 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Pensacola, FL
- Active Since 09/26/2006
- Last Updated 10/04/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1578664140
Products in Payments
- Prod. Category: IVUS Imaging (Device) $2,815
- XARELTO (Drug) $705.52
- ENTRESTO (Drug) $344.95
- COREVALVE EVOLUT R (Device) $305.84
- Mitra Clip system (Device) $206.81
- ELIQUIS (Drug) $200.95
- Vascular Lithotripsy (Device) $187.50
- BRILINTA (Drug) $185.30
- LifeVest (Device) $176.69
- MITRACLIP (Device) $149.86
- FARXIGA (Drug) $148.78
- Impella (Device) $130.13
- Absorb GT1 (Device) $125.00
- NEXLIZET (Drug) $125.00
- GENERAL - STRUCTURAL HEART (Device) $109.87
- GORE CARDIOFORM Septal Occluder (Device) $96.00
- VERQUVO (Drug) $87.02
- PRALUENT (Drug) $72.31
- Resolute (Device) $70.95
- Repatha (Biological) $69.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pensacola
Rohit Amin, Md, MD
Cardiovascular Disease — Payments: $762,056
Franklin Fleischhauer, Md, MD
Cardiovascular Disease — Payments: $165,601
Mark Grise, Md, MD
Cardiovascular Disease — Payments: $86,692
Sergey Kachur, M.d, M.D
Cardiovascular Disease — Payments: $35,457
Dr. David Woodard, M.d, M.D
Cardiovascular Disease — Payments: $15,339
Dr. Marcelo Branco, Md, MD
Cardiovascular Disease — Payments: $13,222